What is Alcyone Therapeutics worth?
$166.5Mlast known valuation
Alcyone Therapeutics last raised $19.0M in its Early Stage VC (Nov 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Alcyone Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2023 | Early Stage VC | $19.0M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $37.1M | ▮ | ▮ |
How Alcyone Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Alcyone Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Alcyone Therapeutics worth?
- Alcyone Therapeutics's last known valuation is $166.5M.
- How much has Alcyone Therapeutics raised?
- Alcyone Therapeutics has raised $71.8M in total funding across 2 recorded rounds.
- When did Alcyone Therapeutics last raise?
- Alcyone Therapeutics last raised in Nov 2023 (Early Stage VC), raising $19.0M.